stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / XNDU

Xanadu Quantum Technologies Limited (XNDU)

Technology · Software - Infrastructure · NasdaqGM

Price
$11.97
Market Cap
$3.57B
P/E Ratio
0.00
EPS
$-0.19
Sector
Technology
52-Week High
$42.44
52-Week Low
$6.97
Dividend Yield

Xanadu Quantum Technologies Limited revenue & earnings — last 3 fiscal years

Metric202320242025
Revenue$2.48M$1.59M$4.62M
Gross profit$1.87M$1.12M$4.26M
Net income$-35.59M$-45.97M$-70.67M
Net margin-1435.7%-2892.9%-1530.6%

Source: Xanadu Quantum Technologies Limited SEC filings (10-K).

Explore 3 years of Xanadu Quantum Technologies Limited financials — interactive

Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.

Open the interactive view — free

Or start a 7-day free trial to track XNDU in your portfolio →

Xanadu Quantum Technologies Limited financial history by metric

About Xanadu Quantum Technologies Limited

Xanadu Quantum Technologies Limited develops and provides photonic quantum computing technology and related software solutions and applications, including cloud-based access to quantum computers and tools for quantum programming and simulation. The company provides access to photonic quantum computers through x-series devices available via the cloud, supporting programmable quantum gates and photon-number resolving detectors. It offers Pennylane, a cross-platform python library that enables a paradigm and quantum differentiable programming that enables integration with machine learning tools; and Catalyst for just-in-time compilation and optimization of quantum algorithms. It also provides users with access to documentation, guides, and community-led resources for quantum machine learning, quantum chemistry simulations, and other quantum computing applications, along with collaboration and support from a team of quantum experts. The company serves professional clients in the quantum computing, software development, and machine learning sectors, as well as advanced users in research and development, including those utilizing high-performance computing and quantum hardware. Xanadu Quantum Technologies Limited was incorporated in 2016 and is based in Toronto, Canada.

Xanadu Quantum Technologies Limited — frequently asked questions

What is Xanadu Quantum Technologies Limited's revenue?

Xanadu Quantum Technologies Limited (XNDU) reported revenue of $4.62M for fiscal year 2025, up 190.6% from the prior year, according to its SEC filings.

Is Xanadu Quantum Technologies Limited profitable?

No — XNDU reported a net loss of $-70.67M in fiscal 2025.

What is XNDU's P/E ratio?

Xanadu Quantum Technologies Limited trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.

How fast is Xanadu Quantum Technologies Limited growing?

XNDU's revenue grew at roughly 36.5% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.

How much debt does Xanadu Quantum Technologies Limited have?

As of fiscal year 2025, XNDU carried roughly $30.00M in total debt (short- plus long-term borrowings), per its filed balance sheet.

What is Xanadu Quantum Technologies Limited's gross margin?

XNDU's gross margin was 92.2% in fiscal 2025 — gross profit of $4.26M on revenue of $4.62M.

What is Xanadu Quantum Technologies Limited's market cap?

Xanadu Quantum Technologies Limited (XNDU) has a market capitalization of about $3.57B, based on the latest data in our nightly-refreshed cache.

When does Xanadu Quantum Technologies Limited's fiscal year end?

XNDU's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.

Where does this data come from?

All figures are computed from Xanadu Quantum Technologies Limited's official SEC filings (10-K and 10-Q), covering 3 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.

Explore more stocks

Browse all 1,500+ companies → · Screen them by fundamentals →